Back to Agenda
Session 5: Product Development
Session Chair(s)
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
- Basic Principles
- Development Considerations
- Patents and Exclusivities
Have an account?
Already a DIA Member? Sign in. Not a member? Join.
Sign in
Not a Member?
DIA Global Center
Oct 28, 2019 8:15 AM - Oct 29, 2019 4:30 PM
21 Dupont Circle NW, Suite 300, Washington, DC 20036
Learn about FDA's approach to regulation of combination products, the processes to streamline development of single entity, and aligning requirements between drugs and devices.
Back to Agenda
President
Regulatory Advantage, LLC, United States
Have an account?